The Office of the Vice President for Research (VPR)
Uniformed Services University of the Health Sciences
Building A, Room A1032
4301 Jones Bridge Road
Bethesda, Maryland 20814
The Office of the Vice President for Research (VPR) was established at USU to facilitate, promote and oversee the research activities at USU. This office monitors, reviews, and coordinates approvals for all matters dealing with research at the University, including the following responsibilities: identification of potential funding sources; pre-award administration; post-award administration; grant award and receipt; administration of the Program for the Protection of Human Participants in Research (PPHPR), including Institutional Review Board (IRB) review and approval; and monitoring of compliance with all federal regulations regarding the conduct of research.
The Office of Research provides service to the following communities: faculty investigators, postdoctoral fellows, students, the University, and the approximately 80 funding organizations that support University research. The roughly 500 active research protocols at USU cover a variety of scientific areas, including basic biomedical areas central to the mission of the Military Health System.
This RFI is issued solely for information and planning purposes and does not constitute a solicitation or issuance thereof.
USU is issuing this Request for Information (RFI) to survey available and/or emerging technologies that have the potential to address the following areas of interest in the detection and management of mTBI:
Utility of the non-invasive technologies, individually or in combination, as initial diagnostic and/or screening tool(s) for individuals who have been exposed to events associated with mTBI (i.e. individuals who have been exposed to scenarios associated with a risk of mTBI, but in whom the diagnosis has not yet been made). The technology or technologies should be compared against current standard(s) of care.
Ability of available and/or emerging biomedical non-invasive technologies, individually or in combination, to provide prognostic information that can among other things, predict return to activity/duty time for those who have been diagnosed with concussion/mTBI when compared to current standard(s) of care/return to activity protocols.
Utility of the non-invasive technologies, individually or in combination, to serve as tools by which inclusion and or exclusion criteria can be determined for entry of individuals into clinical studies of candidate therapeutics in the management of mTBI. Comparative assessment of the technology or technologies should be against current clinical standards (treatment of functional deficits and symptoms related to mTBI will be prioritized).
To facilitate review of responses, please clearly mark which of the above technologies/areas of interest are relevant to the response. DO NOT submit cost related or pricing information in response to this RFI. General marketing information or marketing flyers that do not address the Government’s requirements outlined herein will be not be reviewed.
Please respond no later than 11:59 PM (Eastern) on 27 Jul 2020. Responses should be limited to no more than 5 pages, and must be submitted to mTBItechnologies@usuhs.edu.
An Academic Health Center of the 21st Century is to educate, conduct research and enhance clinical care (through collaborations).
Uniformed Services University of the Health Sciences (USU) has unique aspects of Military Medicine within its mission. DOD, NIH, FDA, CDC, IHS, VA, NSF, and other foundations and non-federal organizations are collaborators and sponsors.